Screening for NRG1 fusions is like searching for a needle in a haystack, and diagnostic strategies can vary from one cancer type to another and from one medical center/healthcare system to another because of various workflow, technical, and medico-economic reasons. This evidence concerns the gene NRG1 and cancer.